AbbVie
ABBV
#35
Rank
$242.69 B
Marketcap
$137.56
Share price
-0.76%
Change (1 day)
-8.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2022 : $17.28 B

According to AbbVie's latest financial reports the company has $17.28 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2022)

Net assets by year

Year Net assets Change
2022-12-31$17.28 B11.99%
2021-12-31$15.43 B17.86%
2020-12-31$13.09 B-260.27%
2019-12-31$-8.18 B-3.24%
2018-12-31$-8.45 B-265.71%
2017-12-31$5.09 B9.94%
2016-12-31$4.63 B17.52%
2015-12-31$3.94 B126.46%
2014-12-31$1.74 B-61.22%
2013-12-31$4.49 B33.57%
2012-12-31$3.36 B-72.49%
2011-12-31$12.22 B-22.16%
2010-12-31$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$95.91 B 454.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.29 B-34.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.34 B-69.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.78 B-20.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.93 B 21.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.88 B 84.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.81 B 107.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
$14.01 B-18.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.68 B-90.26%๐Ÿ‡บ๐Ÿ‡ธ USA